Albemarle's stock is rated as a 'Sell' due to declining revenue and profitability issues. The halving of lithium prices has resulted in an oversupply, creating negative sentiment for the upcoming earnings release. Valuation models, including DDM and DCF, suggest the stock is significantly overvalued, with a fair value much lower than the current price. This combination of factors indicates a likely short-term decline in stock price.